3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Conditions
Glioblastoma
4
Multiple Myeloma
2
Lymphoma
2
Glioma
2
Whooping Cough
1
Sarcoma
1
Recurrence
1
Rectal Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pneumococcal Infections
1
Papillomavirus Infections
1
Pancreatic Neoplasms
1
Neoplasms, Plasma Cell
1
Neoplasms, Germ Cell and Embryonal
1
Neoplasms
1
Neoplasm Metastasis
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Medulloblastoma
1
Measles
1
Lymphoma, Non-Hodgkin
1
Lipodystrophy, Congenital Generalized
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia
1
Human Papillomavirus-Related Cervical Carcinoma
1
Hodgkin Disease
1
Hepatitis B
1
HIV Infections
1
Gliosarcoma
1
Interventions
Cyclophosphamide
87
fludarabine phosphate
86
Peripheral Blood Stem Cell Transplantation
70
Mycophenolic Acid
58
Tacrolimus
57
Busulfan
57
Whole-Body Irradiation
55
Antilymphocyte Serum
47
Cyclosporine
46
fludarabine
39
Methotrexate
38
Filgrastim
38
Melphalan
32
ruxolitinib
30
Cytarabine
30
Radiotherapy
27
Azacitidine
23
Etoposide
21
Methylprednisolone
20
Cord Blood Stem Cell Transplantation
18
Specimen Handling
15
Sirolimus
15
Granulocyte Colony-Stimulating Factor
15
Decitabine
15
Cyclosporins
14
Biopsy
14
Alemtuzumab
14
thymoglobulin
13
venetoclax
11
sargramostim
10
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Myeloproliferative Disorders
×
Tetanus Toxoid
×
Clear all
NCT01611298
2020-04-21
TAR
Baylor College of Medicine
Phase NA
Completed
7 enrolled
8 charts